Geneva, Switzerland – November 18, 2016 – Today, the Sabin Vaccine Institute (Sabin) begins its formal membership with the Coalition for Epidemic Preparedness Innovations (CEPI), as global health leaders gather in Geneva, Switzerland for the first meeting of CEPI’s Joint Coordination Group (JCG).
Beijing, China — September 22, 2016 — The International Association of Immunization Managers (IAIM), based at the Sabin Vaccine Institute (Sabin), today began its first-ever regional meeting for members from Asia and the Pacific in Beijing, China.
Melbourne, Australia — September 7, 2016 — Beginning today, the 12th International Rotavirus Symposium will bring together hundreds of stakeholders from over 50 countries to provide an update on new data and research that will inform public health agendas related to prevention of rotavirus gastroenteritis, the leading cause of severe diarrhea in children worldwide.
Mexico City, Mexico – August 31, 2016 – Today, four leading institutions at the forefront of dengue prevention and control—the International Vaccine Institute (IVI), the International Vaccine Access Center (IVAC) of the Johns Hopkins University, the Partnership for Dengue Control Foundation (PDC) and the Sabin Vaccine Institute—announced a new global alliance to integrate approaches to fight dengue and other Aedes-transmitted diseases under one strategic umbrella. Named the Global Dengue and Aedes-transmitted Diseases Consortium (GDAC), this new partnership will expand its expertise in dengue to other Aedes-transmitted diseases including Zika, chikungunya and yellow fever, responding to the urgent need for coordination in the currently fragmented efforts to control the diseases transmitted by one of the world's most dangerous animals—the Aedes mosquito.
WASHINGTON, D.C. — August 25, 2016 — The Sabin Vaccine Institute announced today that it has received an award of US$468,328 from the U.S. Centers for Disease Control and Prevention (CDC) to support initiatives to improve sustainable immunization financing. The project, conducted in partnership with the Pan American Health Organization (PAHO), will support sustainable financing, planning and decision-making for immunization programs in low- and middle-income countries. The program will launch in the Democratic Republic of Congo, Senegal and Kenya in 2016.
KATHMANDU, NEPAL — July 19, 2016 — The Sabin Vaccine Institute’s Sustainable Immunization Financing (SIF) Program today assembled senior officials from 21 countries to share their successes in increasing government budget allocations for national immunization programs. Greater political commitment and advocacy are building the momentum needed for countries to fully finance their immunization programs by 2020 and achieve the goals set forth in the Global Vaccine Action Plan (GVAP).
KAMPALA, UGANDA — April 28, 2016 — The Sabin Vaccine Institute (Sabin) applauds the enactment of Uganda’s Immunization Act, 2016, which was recently signed into law by President Yoweri Museveni.
WASHINGTON, D.C. — April 19, 2016 — The Sabin Vaccine Institute (Sabin) will present the 2016 Albert B. Sabin Gold Medal Award to George R. Siber, M.D., chief scientific officer of ClearPath Vaccines Company.
Peter Hotez, M.D., Ph.D., president of Sabin, testified this week at two congressional hearings: the House Energy and Commerce Subcommittee on Oversight and Investigations hearing, “Examining the U.S. Public Health Response to the Zika Virus”; and the House Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations on “The Growing Threat of Cholera and Other Diseases in the Middle East.”